Coldstream Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
JT
CAM
Coldstream Capital Management's LGND Position: Q2 2026 in Review
Coldstream Capital Management opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 666 shares worth $211K. The stake represents ﹤0.01% of the portfolio and ranks #1154 among its holdings. This is a return to the name: Coldstream Capital Management previously reported a position in LGND as recently as Q1 2025.
Coldstream Capital Management first reported a position in LGND in Q3 2018 and has held it in 3 quarters since. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- Coldstream Capital Management held 666 shares of Ligand Pharmaceuticals worth $211K as of Q2 2026.
- Ligand Pharmaceuticals was a new Coldstream Capital Management position in Q2 2026.
- Ligand Pharmaceuticals made up ﹤0.01% of Coldstream Capital Management's portfolio in Q2 2026, its #1154 holding.
- Coldstream Capital Management first reported a position in Ligand Pharmaceuticals in Q3 2018 and has held it in 3 quarters since.
- 417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.